Formulation and optimization of Naringin loaded ß-lactoglobulin nanoparticles
DOI:
https://doi.org/10.63682/jns.v14i18S.5266Keywords:
Naringin, ß-Lactoglobulin, nanoparticles, optimization, bioavailabilityAbstract
Protein derived from food-based nanoparticles are of great interest as they are recognized as safe and are easy to prepare. In this work we prepared ß- lactoglobulin nanoparticles for the improved bioavailability of naringin. The effect of pH, temperature, heating time and drug to protein ratio was optimized for particle size, PDI and encapsulation efficiency. The morphological features of the prepared particle revealed smooth spherical particles in clusters. The average particle size of the formulations ranged between 227 nm to 407 nm and the PDI ranged from 0.213 to 0.711. The zeta potential of the prepared ß-Lg nanoparticles was found in the range -4.1 to -7.4 mV suggestive to particle aggregation and the observed size range. The encapsulation of naringin was found in the range of 12.5% to 38.6%. The best formulation (F1) exhibited an encapsulation efficiency of 38.6% with particle size 227 nm and PDI 0.213. The in vitro release of F1 exhibited controlled release of naringin from the nanoparticles for 12 h. The results of the study led to the conclusion that protein nanoparticles (ß-lacotoglobulin) could be an effective method to improve bioavailability of phytomolecules.
Downloads
Metrics
References
Hagan SA, Coombe AGA, Garnett MC, Dunn SE, Davies MC, Illum L, Davis SS. Polylactide-poly(ethylene glycol) copolymers as drug delivery systems 1. Characterization of water dispersible micelle-forming systems. Langmuir 1996, 12, 2153-2162
Eniola AO, Hammer DA. Artificial polymeric cells for targeted drug delivery. J. Control. Release 2003, 87, 15–22
Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 2001, 53, 283–318
Davis SS. Biomedical applications of nanotechnology-implications for drug targeting and gene therapy. Trend. Biotechnol. 1997, 15, 217-224
Kim KY. Nanotechnology platforms and physiological challenges for cancer therapeutics. Nanomed. 2007, 3, 103-110
El-Bagory IM, Honsy EA, Suwayeh AA, Mahrous GM, Jenoobi FIA. Effects of sphere size, polymer to drug ratio and plasticizer concentration on the release of theophylline from ethyl cellulose microspheres. Saudi Pharm. J. 2007, 15, 213-217
Baldasso C, Barros TC, Tessaro IC. Concentration and purification of whey proteins by ultrafiltration. Desalination. 2011, 278(1-3), 381-386.
Jones OG, Lesmes U, Dubin P, McClements DJ. Effect of polysaccharide charge on formation and properties of biopolymer nanoparticles created by heat treatment of β-lactoglobulin-pectin complexes. Food Hydrocolloids. 2010, 24, 374-383.
Livney YD. Milk proteins as vehicles for bioactives. Current Opinion in Colloid & Interface Science. 2010, 15(1-2), 73-83. doi:10.1016/j.cocis.2009.11.002
Liu M, S. Thijssen S, Hennink WE, Garssen J, van Nostrum CF, Willemsen LEM. Oral pretreatment with b-lactoglobulin derived peptide and CpG co-encapsulated in PLGA nanoparticles prior to sensitizations attenuates cow’s milk allergy development in mice. Front. Immunol. 2023, 13:1053107. doi: 10.3389/fimmu.2022.1053107
Koohi Moftakhari Esfahani M, Alavi SE, Cabot PJ, Islam N, Izake EL. β-Lactoglobulin-Modified Mesoporous Silica Nanoparticles: APromising Carrier for the Targeted Delivery of Fenbendazole into Prostate Cancer Cells. Pharmaceutics 2022, 14, 884. https://doi.org/10.3390/pharmaceutics14040884
Duarte Larissa GR, Ferreira Natalia CA, Fiocco Ana Clara TR, Picone Carolina SF. Lactoferrin-chitosan-TPP nanoparticles: antibacterial action and extension of strawberry shelf-life. 2022, PREPRINT (Version 1) available at Research Square https://doi.org/10.21203/rs.3.rs-2112897/v1
Lin D, Su J, Chen S, Wei J, Zhang L, Li X, Yuan F. Formation mechanism of binary complex based on β-lactoglobulin and propylene glycol alginate with different molecular weights: Structural characterization and delivery of curcumin. Front. Nutr. 2022, 9:965600. doi: 10.3389/fnut.2022.965600
Kabedev A, Zhuo X, Leng D, Fodera V, Zhao M, Larsson P, Bergstrom CAS, Lobmann K. Stabilizing Mechanisms of β‑Lactoglobulin in Amorphous Solid Dispersions of Indomethacin. Molecular Pharmaceutics. 2022; 19: 3922-3933. https://doi.org/10.1021/acs.molpharmaceut.2c00397
Yousefi A, Ahrari S, Panahi F, Ghasemi Y, Yousefi R. Binding analysis of the curcumin‑based synthetic alpha‑glucosidase inhibitors to beta‑lactoglobulin as potential vehicle carrier for antidiabetic drugs. Journal of the Iranian Chemical Society. 2022, 19, 489-503. https://doi.org/10.1007/s13738-021-02323-8
Waghmare MN, Qureshi TS, Murali Krishna C, Pansare K, Gadewal N, Hole A, Dongre PM. β-Lactoglobulin-gold nanoparticles interface and its interaction with some anticancer drugs – an approach for targeted drug delivery. Journal of Biomolecular Structure and Dynamics. 2021, 1-25. https://doi.org/10.1080/07391102.2021.1879270
Salah M, Mansour M, Zogona D, Xu X. Nanoencapsulation of anthocyanins-loaded β-lactoglobulin nanoparticles: Characterization, stability, and bioavailability in vitro. Food Research International. 2020, 137, 109635. https://doi.org/10.1016/j.foodres.2020.109635
Kanaze FI, Bounartzi MI, Georgarakis M, Niopas I. Pharmacokinetics of the citrus flavanone aglycones hesperetin and naringenin after single oral administration in human subjects. European Journal of Clinical Nutrition. 2007, 61, 472–477.
Guo Y. Production of nanoparticles with Beta lactoglobulin and whey proteins for the encapsulation of food ingredients. PhD dissertation, Department of Food and Nutritional Science, University of Reading, United Kingdom, 2017.
Cordenonsi LM, Sponchiado RM, Campanharo SC, Garcia CV, Raffin RP, Schapova EES. Study of Flavonoids presente in Pomelo (Citrus máxima) by DSC, UV-VIS, IR, 1H AND 13C NMR and MS. Drug Analytical Research. 2017, 01, 31-37.
Mishra A, Kondalkar AK, Lal M, Tripathi D, Singh N. Formulation and characterization of chrysin loaded niosomal vesicular delivery system. Journal of Pharmacology and Biomedicine. 2023, 7(4), 642-650
Mishra BJ, Kaul A, Trivedi P. L-Cysteine conjugated poly l-lactide nanoparticles containing 5-fluorouracil: formulation, characterization, release and uptake by tissues in vivo. Drug Delivery. 2015, 22(2), 214-222
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
